Found 70 matching trials
Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers PHASE1 This trial is part of the Horizon 2020 project, REPO-TRIAL, on in-silico, m...
Show More Location
UniversitätsKlinikum Heidelberg - Medizinische Klinik
Learn More & Join Trial
A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants PHASE1 The purpose of this study is to evaluate the effect of macitentan at steady...
Show More Location
Clinical Pharmacology Unit
Learn More & Join Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) N/A The aim of the study is to assess safety, tolerability and clinical effects...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies N/A A surveillance of respiratory tract related adverse events in patients trea...
Show More Location
Cardiovascular Associates, P.C.
Learn More & Join Trial
Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction PHASE2 The primary objective of this study is to
• Assess the pharmacodynamic pro...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Riociguat in Children With Pulmonary Arterial Hypertension (PAH) PHASE3 This study was designed to evaluate the safety, tolerability, pharmacodynam...
Show More Status
Active Not Recruiting
Location
Clínica Imbanaco S.A.S
Learn More & Join Trial
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy PHASE4 What is this study about? This study will test whether adding sotatercept t...
Show More Location
Kyushu University Hospital
Learn More & Join Trial
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. PHASE4 To provide riociguat therapy to eligible patients with PAH originating from...
Show More Location
Multiple Locations
Learn More & Join Trial
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension PHASE3 Patients who have completed the 12 weeks treatment of the PATENT-1 trial (s...
Show More Location
Multiple Locations
Learn More & Join Trial
Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty PHASE3 Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but severe ...
Show More Learn More & Join Trial